Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations.
about
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effectsProgestogen safety and tolerance in hormonal replacement therapy.Drugs for the treatment of menopausal symptoms.Premature surgical menopause and Factor V Leiden heterozygosity: case report and literature review.Different Effects of Oral Contraceptive and Dydrogesterone Treatment on Oxidative Stress Levels in Premenopausal Women.
P2860
Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Risk of cardiovascular outcome ...... one or other HRT preparations.
@en
Risk of cardiovascular outcome ...... one or other HRT preparations.
@nl
type
label
Risk of cardiovascular outcome ...... one or other HRT preparations.
@en
Risk of cardiovascular outcome ...... one or other HRT preparations.
@nl
prefLabel
Risk of cardiovascular outcome ...... one or other HRT preparations.
@en
Risk of cardiovascular outcome ...... one or other HRT preparations.
@nl
P2860
P1433
P1476
Risk of cardiovascular outcome ...... one or other HRT preparations.
@en
P2093
P2860
P304
P356
10.1080/13697130902780853
P577
2009-10-01T00:00:00Z